Zydus Pharms Usa Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZYDUS PHARMS USA INC, and what generic and branded alternatives to ZYDUS PHARMS USA INC drugs are available?
ZYDUS PHARMS USA INC has thirty-six approved drugs.
There are seventeen tentative approvals on ZYDUS PHARMS USA INC drugs.
Drugs and US Patents for Zydus Pharms Usa Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zydus Pharms Usa Inc | LAMOTRIGINE | lamotrigine | TABLET, FOR SUSPENSION;ORAL | 078009-002 | Jan 22, 2009 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Zydus Pharms Usa Inc | MYCOPHENOLATE MOFETIL | mycophenolate mofetil | CAPSULE;ORAL | 065433-001 | May 4, 2009 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Zydus Pharms Usa Inc | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 090174-002 | Apr 14, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ZYDUS PHARMS USA INC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.